Tonglu Wanhe Medical Instrument Co., Ltd.
For the better life!
Add to Cart
| Model | Name | Specifications |
| HF3010 | Measuring bar | Φ5x500mm |
| HF3017 | Myoma drill | Φ10x400mm |
| HF3018 | Myoma drill | Φ5x400mm |
| HF2009 | Knot pusher | Φ5x330mm |
| HF3011 | Palpation probe | Φ5x450mm |
| HF3009 | Uterine maipulator | / |
| HF3007 | Intrauterine forceps | / |
| HF3009.1 | Simple uterine manipulator | 250mm |
| Package detail: | Poly bag and special shockproof paper box. |
| Delivery detail: | By air |
FAQ
Minimally invasive gynecological surgery is usually used to treat the following gynecological diseases:
Uterine fibroids: This is the most common benign tumor in women, and minimally invasive surgery is its preferred treatment method.
Ovarian cysts: Including benign ovarian tumors and ovarian chocolate cysts.
Endometriosis: This disease forms ectopic lesions in the pelvic cavity, and minimally invasive surgery can be effectively treated.
Ectopic pregnancy (ectopic pregnancy): Minimally invasive surgery is the preferred treatment for ectopic pregnancy.
Infertility: Minimally invasive surgery can help diagnose and treat the causes of infertility.
Ovarian teratoma: This is a benign tumor that can be effectively removed with minimally invasive surgery.
Pelvic mass: Masses in the pelvic cavity can be diagnosed and treated with minimally invasive surgery.
Adenomyosis: This disease involves the growth of endometrial tissue in the myometrium, and minimally invasive surgery can be effectively treated.
Ovarian crown cyst: This is a benign tumor that can be effectively removed with minimally invasive surgery.
Cervical lesions: including cervical polyps, cervical septa, etc., can be removed or repaired by minimally invasive surgery.
These diseases have the advantages of less trauma, faster recovery, and less pain through minimally invasive surgery, which can significantly improve patients' symptoms and quality of life.
When treating uterine fibroids, the latest technologies and methods of minimally invasive gynecological surgery include the following:
Ultrasound-guided radiofrequency ablation of uterine fibroids: This technology uses the heat energy generated by high-frequency electromagnetic waves to accurately act on uterine fibroids, which is a physical ablation treatment method.
High-intensity focused ultrasound (HIFU) technology: HIFU technology is a non-invasive treatment method that has attracted attention at international minimally invasive surgery conferences, and the original HIFU technology in China has also been used.
Microwave ablation therapy: Microwave ablation therapy is similar to radiofrequency ablation therapy, with the advantages of high thermal efficiency, low cost, and definite efficacy.
Hysteroscopic myomectomy: This technology removes uterine fibroids through hysteroscopy, with less trauma and faster recovery.
Single-port laparoscopic minimally invasive technology: This technology has been widely used in gynecological malignancies, complex intrauterine adhesions, and transurethral resection of submucosal uterine myomas.
The success rate of minimally invasive surgery for ovarian cysts is high. Usually, patients recover well and have a good prognosis after surgery. However, despite the low risk of surgery, some complications may still occur.
Possible complications include:
Incision infection: The wound may become infected after surgery, requiring anti-infection treatment and regular dressing changes.
Fat liquefaction: Fat liquefaction may occur after surgery.
Intestinal adhesions: Intestinal adhesions may occur during surgery.
Aspiration pneumonia: Aspiration pneumonia may occur after surgery.
Deep vein thrombosis: Deep vein thrombosis may form after surgery.
Decreased ovarian function on one side: Surgery may cause decreased ovarian function on one side.
Infertility: Surgery may increase the incidence of infertility.
Recurrent cysts: Recurrent cysts may occur after surgery.
Damage to other organs: Other organs may be damaged during surgery.
In addition, if the patient has chronic diseases such as diabetes or obesity, the risk of these complications increases.
The long-term prognosis after minimally invasive surgery for endometriosis depends on many factors, including patient compliance, postoperative management, and personalization of the treatment plan.
It takes about three months to recover after surgery, and patients need to follow the doctor's advice, take medication on time, have regular checkups, and pay attention to the recovery of their bodies. In addition, non-drug pain management has a positive effect on postoperative recovery and quality of life.
Postoperative recurrence is an important problem in endometriosis. Although surgery can effectively relieve symptoms, the lesions may continue to grow under the influence of after surgery, leading to recurrence. Therefore, postoperative drug-assisted treatment and chronic disease management mode are essential to prevent recurrence and improve the quality of life.
In addition, the quality of life of postoperative patients is also affected by many factors, including sleep quality, exercise intensity, menstrual cycle, duration of dysmenorrhea, and pain scores. Studies have shown that patients who undergo surgery have significantly improved sleep quality and depressive symptoms, which helps improve the overall quality of life.
The long-term prognosis after minimally invasive surgery for endometriosis is closely related to the patient's compliance, postoperative management and personalized treatment plan.
The best time and selection criteria for minimally invasive surgery for ectopic pregnancy are as follows:
The best time for ectopic pregnancy surgery is within 30-50 days of pregnancy. During this period, if an ectopic pregnancy is discovered and diagnosed, surgical treatment is usually recommended. The earlier the treatment, the less harm to the body, which can reduce unnecessary trouble.
Selection criteria:
Whether it is ruptured: If the ectopic pregnancy has not ruptured and there is a strong desire for fertility, conservative treatment with drug injections (such as methotrexate) can be considered.
Whether to retain the fallopian tube: Depending on whether the patient has the need to retain the fallopian tube, conservative surgery or radical surgery can be selected.
Severity of the disease: If the ectopic pregnancy has ruptured or the gestational sac is large, surgery is often required to terminate the pregnancy.
The latest progress and effect evaluation of minimally invasive surgical treatment for infertility are mainly focused on the following aspects:
Application of hysteroscopic and laparoscopic technology: In recent years, hysteroscopic and laparoscopic technology has been widely used in the treatment of infertility. This technology can not only effectively diagnose and treat gynecological diseases, but also significantly improve the reproductive outcomes of patients. For example, at the 2024 Beijing International Hysteroscopic and Laparoscopic and Gynecological Minimally Invasive Surgery Symposium, the progress of gynecological minimally invasive technology was discussed and relevant case reports were shared.
Effect of laparoscopic minimally invasive surgery: Laparoscopic minimally invasive surgery has performed well in the treatment of infertility-related diseases such as endometriosis. Studies have shown that compared with traditional open surgery, laparoscopic minimally invasive surgery has the advantages of fast recovery and less trauma.
Academic exchanges and standardized diagnosis and treatment: In order to promote the latest treatment guidelines for infertility and reproductive endocrine diseases, many academic seminars and lecture tours have been held in China. These activities aim to clarify vague concepts in diagnosis and treatment and promote standardized diagnosis and treatment.
Exploration and application of new technologies: At the 2022 Xi'an International Symposium on New Advances in Gynecology and Minimally Invasive Surgery, core topics such as the clinical application of common gynecological laparoscopy were discussed, and new technologies and advances in the medical field were demonstrated.
Conferences and seminars: Many cities have held seminars on new advances in minimally invasive surgery for infertility, such as conferences in Guangzhou and Hangzhou, inviting many experts from across the country to discuss and share the latest research results and experiences.
The latest progress in minimally invasive surgical treatment of infertility is mainly reflected in the widespread application of hysteroscopy and laparoscopy technology, the significant effects of laparoscopic minimally invasive surgery, the promotion of academic exchanges and standardized diagnosis and treatment, and the exploration and application of new technologies.
For more photos and details please contact me:
Company Name: Tonglu Wanhe Medical Instruments Co., Ltd.
Sales Manager: Sue